Global trial ends 20-year debate over gastro-esophageal cancer treatment
Cancer patients could avoid unnecessary radiation therapy as a result of an international clinical trial, led by Peter Mac ...
T-Net2d
Eupraxia Pharmaceuticals Announces Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to optimize drug delivery for applications with significant unmet need, ...
Medindia1d
Eupraxia Pharmaceuticals to Present at 20th ISDE World Congress for Esophageal Diseases
PP02.05 Initial Results from RESOLVE, a Phase 1b Dose-Escalation Study of EP-104GI (Extended-Release Fluticasone ...
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission ...
Medscape2d
Recent Advances in the Treatment of Eosinophilic Esophagitis
Treatment includes pharmacologic therapy, dietary exclusions and mechanical dilatation. As more research identifies the impact of esophageal remodeling and fibrosis, new treatments targeting this ...
Deccan Herald3d
Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian market
New Delhi: Home-grown pharma major Lupin Ltd on Wednesday said it has entered into a non-exclusive patent licence agreement ...
Medscape4d
Treatment of Esophageal Varices With Carvedilol
Nonselective beta blockers or endoscopic band ligation (EVL) are recommended for primary prophylaxis of variceal bleeding in patients with esophageal ... the pharmacologic treatment of portal ...
Henlius and Intas receive Positive CHMP Opinion for HETRONIFLY® (approved as HANSIZHUANG in China) in European markets as First-Line Treatment for adult pati…
HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...
Medindia17h
Henlius Receives Positive CHMP Opinion for HANSIZHUANG as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
HANSIZHUANG (serplulimab) is the world's first anti-PD-1 mAb for first-line treatment of ES-  SCLC   - HANSIZHUANG (serplulimab) is expected to become the first and only anti-PD-1 ...
At 51, I Got a Shocking Diagnosis—but They Refused Me Life-Saving Treatment
Soon after my diagnosis, my doctor told me I had two years left to live—if I was lucky. This prognosis was due to the state of my liver function measured by the model for end-st ...